Researchers in Japan have tested a prototype 256-slice CT scanner in human patients, according to a study in the July issue of the American Journal of Roentgenology. The technology enabled dynamic imaging of liver cancer in real-time.
Researchers in Japan have tested a prototype 256-slice CT scanner in human patients, according to a study in the July issue of the American Journal of Roentgenology. The technology enabled dynamic imaging of liver cancer in real-time.
Imagers have been able to perform contrast-enhanced 3D imaging of the liver's arterial phase using 16-slice CT scanners, albeit with limitations. Current MSCT detector technology would not be able to obtain more than one image per second of a descending contrast agent bolus.
Dr. Shinichiro Mori and colleagues from research institutions in Chiba and Osaka used an experimental MSCT scanner in three randomly selected patients with hepatocellular carcinomas. They were able to detect all lesions using dynamic contrast enhancement in an almost simultaneous volumetric imaging cine mode.
Dynamic 256-slice CT obtained continuous 3D coronal renderings 30 seconds after contrast injection. The hepatic veins, abdominal aorta, and renal arteries were best visualized at 30, 34, and 36 seconds after injection, respectively. The technique also allowed observation of the backflow of contrast material to the inferior vena cava in one patient experiencing heart failure.
Investigators applied an imaging protocol including the following parameters:
The 256-slice scanner allowed superior cine imaging reconstructions of structures with a craniocaudal distance of approximately 10 cm in any plane with several postprocessing techniques including full-volume renderings and maximum intensity projections.
The system can cover one or more organs during one phase of contrast enhancement. It could also produce functional studies of the head, liver, and renal and coronary arteries, investigators noted in the study.
For more information from the Diagnostic Imaging archives:
64-slice scanners build case for coronary CTA
Single-phase, multislice CT aids pancreatic cancer detection
Jog-shuttle wheel turns heads and wrists
Why stop at 16? CT imagers predict 256-row scanners
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.